Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Perlman

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Biochemistry|February 6, 1990
13C and 15N nuclear magnetic resonance evidence of the ionization state of substrates bound to bovine dihydrofolate reductaseB S Selinsky, M E Perlman, R E London, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Identification and characterization of a potential ischemia-selective N-methyl-D-aspartate (NMDA) receptor ion-channel blocker, CNS 5788S Padmanabhan, M E Perlman, L Zhang, et al.
Journal of Medicinal Chemistry|November 1, 1985
Synthesis and properties of bis(2,2-dimethylaziridinyl)phosphinic amides: a series of new antineoplastic agentsJ E MacDiarmid, W C Rose, W C Biddle, et al.
International Journal of Pharmaceutics|November 21, 2007
Development of a self-emulsifying formulation that reduces the food effect for torcetrapibM E Perlman, S B Murdande, M J Gumkowski, et al.
Journal of Medicinal Chemistry|April 1, 1991
Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moietiesM E Perlman, J A Dunn, T A Piscitelli, et al.
Nuclear Medicine and Biology|November 1, 2000
Synthesis and binding characteristics of N-(1-naphthyl)-N'-(3-[(125)I]-iodophenyl)-N'-methylguanidine ([(125)I]-CNS 1261): a potential SPECT agent for imaging NMDA receptor activationJ Owens, A A Tebbutt, A L McGregor, et al.
Journal of Medicinal Chemistry|August 14, 1998
Synthesis and pharmacological evaluation of N,N'-diarylguanidines as potent sodium channel blockers and anticonvulsant agentsN L Reddy, W Fan, S S Magar, et al.
Journal of Medicinal Chemistry|July 31, 1998
Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N,N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channelsM C Maillard, M E Perlman, O Amitay, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Solution-phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockersS Padmanabhan, R C Lavin, P M Thakker, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biochemistry|February 6, 1990
13C and 15N nuclear magnetic resonance evidence of the ionization state of substrates bound to bovine dihydrofolate reductaseB S Selinsky, M E Perlman, R E London, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Identification and characterization of a potential ischemia-selective N-methyl-D-aspartate (NMDA) receptor ion-channel blocker, CNS 5788S Padmanabhan, M E Perlman, L Zhang, et al.
Journal of Medicinal Chemistry|November 1, 1985
Synthesis and properties of bis(2,2-dimethylaziridinyl)phosphinic amides: a series of new antineoplastic agentsJ E MacDiarmid, W C Rose, W C Biddle, et al.
International Journal of Pharmaceutics|November 21, 2007
Development of a self-emulsifying formulation that reduces the food effect for torcetrapibM E Perlman, S B Murdande, M J Gumkowski, et al.
Journal of Medicinal Chemistry|April 1, 1991
Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moietiesM E Perlman, J A Dunn, T A Piscitelli, et al.
Nuclear Medicine and Biology|November 1, 2000
Synthesis and binding characteristics of N-(1-naphthyl)-N'-(3-[(125)I]-iodophenyl)-N'-methylguanidine ([(125)I]-CNS 1261): a potential SPECT agent for imaging NMDA receptor activationJ Owens, A A Tebbutt, A L McGregor, et al.
Journal of Medicinal Chemistry|August 14, 1998
Synthesis and pharmacological evaluation of N,N'-diarylguanidines as potent sodium channel blockers and anticonvulsant agentsN L Reddy, W Fan, S S Magar, et al.
Journal of Medicinal Chemistry|July 31, 1998
Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N,N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channelsM C Maillard, M E Perlman, O Amitay, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Solution-phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockersS Padmanabhan, R C Lavin, P M Thakker, et al.
Pageof 2